Purchase disclosed
Mark Lappe
Chief Executive Officer
Common Stock
- Reported value
- $328.63K
- Reported price
- $98.8659 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Inhibrx Biosciences, Inc.
Last 30 daysInsiders bought $5.5M · 3 buyers, led by Mark Lappe (CEO) with $3.64M. Sales: $279.01K by 1 insider.
Showing the first 6 of 14 trades on this page.
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Executive Officer | Common StockPurchase2 trades | 5,500avg $99.16 / share | $545.36K | Sep 25Filed Sep 28 · 3d later | 2 filings
|
| Chief Executive Officer | Common StockPurchase2 trades | 4,500avg $100.76 / share | $453.43K | Sep 28Filed Sep 28 · 0d later | 2 filings
|
| Director | Common StockPurchase | 5,000$100.00 / share | $500K | Sep 23Filed Sep 23 · 0d later | SEC filing |
| Director | Common StockPurchase | 5,000$100.00 / share | $500K | Sep 16Filed Sep 17 · 1d later | SEC filing |
| Director | Common StockPurchase | 5,000$113.52 / share | $567.58K | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Common StockPurchase | 2,500$114.65 / share | $286.62K | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Chief Executive Officer | Common StockPurchase6 trades | 25,000avg $105.82 / share | $2.65M | Sep 8Filed Sep 8 · 0d later | 6 filings
|
This reflects the filings imported so far, not a complete trading history.
$5,098,421 of common-equity purchase value after transaction-age decay across 180 days.
3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
3 buying groups inside 30 transaction-date days, public by the snapshot cutoff.
A reporting-owner group bought on at least two distinct dates within the cluster window.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.